1 MONTELUKAST SODIUM | 370 of 4500 | 3750 prescriptions Less than 1% of all prescriptions | 2780 | 850 patients 21% of all patients | 670 patients 17% of all patients | |
2 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 10 of 3750 | 3860 prescriptions Less than 1% of all prescriptions | 3170 | 930 patients 23% of all patients | 790 patients 20% of all patients | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 1210 of 4230 | 1110 prescriptions Less than 1% of all prescriptions | 1000 | 250 patients 6% of all patients | < 11 | |
4 FLUTICASONE PROPIONATE | 410 of 3510 | 920 prescriptions Less than 1% of all prescriptions | 790 | 440 patients 11% of all patients | < 11 | |
5 OMEPRAZOLE | 130 of 1560 | 1010 prescriptions Less than 1% of all prescriptions | 770 | 300 patients 7% of all patients | < 11 | |
6 PREDNISONE | 1330 of 4670 | 1050 prescriptions Less than 1% of all prescriptions | 860 | 650 patients 16% of all patients | < 11 | |
7 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 120 of 1840 | 870 prescriptions Less than 1% of all prescriptions | | 210 patients 5% of all patients | < 11 | |
8 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 40 of 930 | 770 prescriptions Less than 1% of all prescriptions | 400 | 190 patients 5% of all patients | < 11 | |
9 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1460 of 4560 | 760 prescriptions Less than 1% of all prescriptions | 610 | 250 patients 6% of all patients | < 11 | |
10 PROAIR HFA (ALBUTEROL SULFATE) | 860 of 4320 | 810 prescriptions Less than 1% of all prescriptions | 610 | 280 patients 7% of all patients | < 11 | |
11 VENTOLIN HFA (ALBUTEROL SULFATE) | 1120 of 4490 | 650 prescriptions Less than 1% of all prescriptions | 330 | 210 patients 5% of all patients | < 11 | |
12 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 900 of 3370 | 470 prescriptions Less than 1% of all prescriptions | | 140 patients 3% of all patients | < 11 | |
13 SPIRIVA (TIOTROPIUM BROMIDE) | 1120 of 4040 | 340 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 1420 of 4380 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 450 of 2130 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 RANITIDINE HCL | 200 of 470 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 ALPRAZOLAM | 360 of 1310 | 240 prescriptions Less than 1% of all prescriptions | 240 | 110 patients 3% of all patients | 110 patients 3% of all patients | |
18 FAMOTIDINE | 230 of 490 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
19 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 610 of 2150 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
20 ESBRIET (PIRFENIDONE) | 320 of 1250 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
21 FLUTICASONE-SALMETEROL (FLUTICASONE PROPION/SALMETEROL) | 180 of 320 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 FUROSEMIDE | 800 of 2470 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
23 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 1350 of 3700 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 METOCLOPRAMIDE HCL | 140 of 250 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 ZOLPIDEM TARTRATE | 470 of 1280 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 CHANTIX (VARENICLINE TARTRATE) | 150 of 450 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 DULERA (MOMETASONE/FORMOTEROL) | 260 of 850 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
28 OFEV (NINTEDANIB ESYLATE) | 400 of 1150 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
29 DIAZEPAM | 50 of 120 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
30 AZITHROMYCIN | 1050 of 3840 | 390 prescriptions Less than 1% of all prescriptions | 270 | 350 patients 9% of all patients | 240 patients 6% of all patients | A |